Robert W. Stewart

ORCID: 0000-0003-1636-846X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Transplantation: Methods and Outcomes
  • Cardiac Valve Diseases and Treatments
  • Cardiac Structural Anomalies and Repair
  • Cardiac and Coronary Surgery Techniques
  • Cardiac, Anesthesia and Surgical Outcomes
  • Congenital Heart Disease Studies
  • Renal Transplantation Outcomes and Treatments
  • Mechanical Circulatory Support Devices
  • Infective Endocarditis Diagnosis and Management
  • Organ Transplantation Techniques and Outcomes
  • Viral Infections and Immunology Research
  • Coronary Artery Anomalies
  • Cardiac tumors and thrombi
  • Cardiac Arrest and Resuscitation
  • Aortic Disease and Treatment Approaches
  • Coronary Interventions and Diagnostics
  • Tracheal and airway disorders
  • Cardiac Imaging and Diagnostics
  • Organ and Tissue Transplantation Research
  • Polyomavirus and related diseases
  • Cardiac Ischemia and Reperfusion
  • Cardiac Arrhythmias and Treatments
  • Cardiomyopathy and Myosin Studies
  • Venous Thromboembolism Diagnosis and Management
  • Ethics in Business and Education

Cleveland Clinic
1996-2022

NIHR Surgical Reconstruction and Microbiology Research Centre
2019

Biomedical Research Institute
2019

University of Zagreb
2019

University of Houston
1981-2012

Walter Reed Army Institute of Research
2008-2010

Baghdad Medical City
2008

Mayo Clinic Hospital
2007

Northwestern University
2006

University Hospitals of Cleveland
1999-2004

We compared patients who received an internal-mammary-artery graft to the anterior descending coronary artery alone or combined with one more saphenous-vein grafts (n = 2306) had only bypass 3625). The 10-year actuarial survival rate among group receiving graft, as vein (exclusive of hospital deaths), was 93.4 percent versus 88.0 (P 0.05) for those one-vessel disease; 90.0 79.5 (P<0.0001) two-vessel and 82.6 71.0 three-vessel disease. After adjustment demographic clinical differences by Cox...

10.1056/nejm198601023140101 article EN New England Journal of Medicine 1986-01-02

Reduced preload and afterload to the heart are important effects of angiotensin converting enzyme (ACE) inhibitors in treatment congestive failure. However, since II (Ang II) directly increases strength myocardial contraction, suppression Ang formation by ACE could potentially reduce beneficial on failing heart. To study how inhibition suppresses cardiac man, we characterized ACE-dependent ACE-independent II-forming pathways eight normal 24 human hearts obtained at transplantation. activity...

10.1161/01.res.66.4.883 article EN Circulation Research 1990-04-01

The mechanisms of chronic atrial fibrillation (AF) are not well understood. We performed epicardial mapping AF in patients undergoing open heart surgery to test the hypothesis that is due a left "driver" with regular, short cycle length, resulting fibrillatory conduction rest atria.Nine (1 month >15 years' duration) were studied at surgery, 8 before and 1 during cardiopulmonary bypass. During AF, electrograms (AEGs) recorded for 5 minutes from 404 electrodes arranged bipoles along ECG lead...

10.1161/01.cir.0000147781.02738.13 article EN Circulation 2004-11-03

10.1016/s0022-5223(19)35841-6 article EN publisher-specific-oa Journal of Thoracic and Cardiovascular Surgery 1986-11-01

We analyzed trends in clinical, angiographic, and operative variables documented long-term survival 2509 consecutive patients who underwent reoperation for myocardial revascularization at The Cleveland Clinic during a 20-year period (1967 to 1987). were grouped into four cohorts by year of surgery. This analysis showed that vein graft atherosclerosis has become the leading indication reoperation, patient age interval between operations continue increase. Mortality rates ranged from 2% 5%...

10.1097/00000658-199009000-00016 article EN Annals of Surgery 1990-09-01

To demonstrate the existence and help clarify function of angiotensin II (Ang II) receptors in human heart, we characterized cardiac Ang receptor examined levels distribution ventricular normal (n = 6) failing 14) hearts. were using agonist [125I]Ang II. Cardiac II-binding sites high affinity (Kd, ∼ 1 nmol/L) low capacity (Bmax, 3 fmol/mg membrane protein) pharmacologically specific [IC50 values for II, [Sar1Ile8]Ang III 1.2, 3.0, 400 nmol/L, respectively; inactive metabolite Ang-(1–5), at a...

10.1210/jcem-69-1-54 article EN The Journal of Clinical Endocrinology & Metabolism 1989-07-01

The direct effects of angiotensin II (Ang II) on human cardiac muscle were investigated using isolated trabecular muscles from failing and functionally normal hearts. Atrial ventricular trabeculae studied. Results demonstrated a positive inotropic effect Ang muscle. Comparison the among groups indicated that responsiveness tended to be greater in atrial compared with this study also heterogeneity muscles, which was not correlated patient age, sex, diagnosis, prior treatment converting enzyme...

10.1161/01.cir.82.6.1973 article EN Circulation 1990-12-01

Background —Most studies indicate that failing human hearts have greater baseline myofibrillar Ca 2+ sensitivity of tension development than nonfailing hearts. Phosphorylation cardiac troponin I (TnI) by cAMP-dependent protein kinase (PKA) decreases the affinity complex for , thus altering force production. We tested hypothesis PKA-dependent TnI phosphorylation is altered in heart and investigated changes PKA regulatory subunits as a potential mechanism. Methods Results —Using vitro...

10.1161/01.cir.99.4.505 article EN Circulation 1999-02-02

A total of 5,070 patients 65 years age or older underwent primary elective coronary bypass surgery at The Cleveland Clinic Foundation from January 1976 through June 1986. These were divided by into two groups, 65-74 and 75 older; these groups compared with each other younger than years. With advancing age, there was a significantly greater prevalence women, more severe angina, diabetes, peripheral vascular disease, previous cerebral events, cardiac enlargement, left main artery disease....

10.3949/ccjm.55.1.23 article EN Cleveland Clinic Journal of Medicine 1988-01-01
Barbara Hasse Margaret M. Hannan Peter M. Keller Florian P. Maurer Rami Sommerstein and 90 more Dominik Mertz Dirk Wagner Núria Fernández-Hidalgo Jim Nomura Vinicio Manfrin Dominique Béttex Antonio Hernandez Conte Emanuele Durante‐Mangoni Tao Tang Rhonda L. Stuart Johan Lundgren Steven M. Gordon M. Claire Jarashow Peter W. Schreiber Stefan Niemann Thomas A. Kohl Charles L. Daley Andrew J. Stewardson Cynthia Whitener Kiran M. Perkins D. Plachouras Theresa Lamagni Meera Chand Tomáš Freiberger Sandrine Zweifel Peter Sander Bettina Schulthess James Scriven Hugo Sax Jakko van Ingen Carlos A. Mestres Daniel J. Diekema Barbara A. Brown‐Elliott Richard J. Wallace Larry M. Baddour José M. Miró Bruno Hoen Eugene Athan Antony Bayer Bruno Baršić G. Ralph Corey Vivian H. Chu David T. Durack Cláudio Querido Fortes Vance G. Fowler Bruno Hoen A.W. Krachmer E. Durante-Magnoni José M. Miró Walter R. Wilson Larry M. Baddour Daniel J. Diekema Núria Fernández-Hidalgo Steven M. Gordon Barbara Hasse Johan Lundgren Vinicio Manfrin Jim Nomura James Scriven Robert W. Stewart Dirk Wagner Tao Tang Loreen A. Herwaldt Dominik Mertz Hugo Sax Peter W. Schreiber Rami Sommerstein Andrew J. Stewardson Cynthia Whitener Andreas F. Widmer B.A. Brown Elliot Charles L. Daley Tomáš Freiberger Jakko van Ingen Peter M. Keller Thomas A. Kohl Florian P. Maurer Stefan Niemann Richard J. Wallace Volkmar Falk Maximilian Halbe Carlos A. Mestres Sandrine Zweifel Dominique Béttex Antonio Hernandez Conte Meera Chand M. Claire Jarashow Theresa Lamagni D. Plachouras Kiran M. Perkins

10.1016/j.jhin.2019.10.009 article EN cc-by-nc-nd Journal of Hospital Infection 2019-11-09
Coming Soon ...